ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,29355
-0,98%
Bitcoin
69.250,00
-0,12%
Brent Oil
79,395
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Odonate Therapeutics Inc (ODT)

  7. Odonate Therapeutics Inc (ODT) Notícias

ODT

Odonate Therapeutics (ODT)

Odonate Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ODT
DataHoraFonteTítuloCódigoCompanhia
10/02/202214:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ODTOdonate Therapeutics Inc
07/02/202211:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ODTOdonate Therapeutics Inc
31/01/202208:14Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ODTOdonate Therapeutics Inc
26/01/202211:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ODTOdonate Therapeutics Inc
26/01/202211:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ODTOdonate Therapeutics Inc
25/01/202219:31Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ODTOdonate Therapeutics Inc
07/01/202211:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ODTOdonate Therapeutics Inc
07/01/202211:00Business WireOdonate Announces Expected Delisting of Its StockNASDAQ:ODTOdonate Therapeutics Inc
10/12/202120:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ODTOdonate Therapeutics Inc
22/11/202113:09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ODTOdonate Therapeutics Inc
17/11/202109:45Business WireOdonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase PlanNASDAQ:ODTOdonate Therapeutics Inc
10/11/202119:15Business WireOdonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021NASDAQ:ODTOdonate Therapeutics Inc
10/11/202119:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ODTOdonate Therapeutics Inc
08/09/202108:00GlobeNewswire Inc.SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the FirmNASDAQ:ODTOdonate Therapeutics Inc
27/07/202109:30Business WireOdonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021NASDAQ:ODTOdonate Therapeutics Inc
02/07/202117:07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ODTOdonate Therapeutics Inc
01/06/202117:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ODTOdonate Therapeutics Inc
14/05/202109:30Business WireOdonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021NASDAQ:ODTOdonate Therapeutics Inc
12/04/202109:02Edgar (US Regulatory)Schedule 13gNASDAQ:ODTOdonate Therapeutics Inc
22/03/202109:00Business WireOdonate Therapeutics Announces Discontinuation of Development of TesetaxelNASDAQ:ODTOdonate Therapeutics Inc
23/02/202110:30Business WireOdonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020NASDAQ:ODTOdonate Therapeutics Inc
23/02/202110:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ODTOdonate Therapeutics Inc
23/02/202109:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ODTOdonate Therapeutics Inc
11/12/202012:05Business WirePositive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 S...NASDAQ:ODTOdonate Therapeutics Inc
07/12/202010:30Business WireOdonate Therapeutics Initiates Cohort 3 of CONTESSA TRIO to Evaluate Tesetaxel Monotherapy in Patients with Metastatic Breast...NASDAQ:ODTOdonate Therapeutics Inc
01/12/202010:30Business WireOdonate Therapeutics to Host Virtual Investor and Analyst Event on December 11, 2020NASDAQ:ODTOdonate Therapeutics Inc
27/11/202011:01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ODTOdonate Therapeutics Inc
28/10/202009:30Business WireOdonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2020NASDAQ:ODTOdonate Therapeutics Inc
05/10/202009:30Business WireResults of CONTESSA, a Phase 3 Study of Tesetaxel in the Treatment of Patients with Metastatic Breast Cancer, to Be Presented...NASDAQ:ODTOdonate Therapeutics Inc
27/08/202020:45Business WireOdonate Therapeutics Announces Pricing of Public Offering of Shares of Common StockNASDAQ:ODTOdonate Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ODT

Seu Histórico Recente

BOV
PRIO3
PETRORIO ON
BOV
IBOV
Índice Bovespa
BOV
SGPS3
SPRINGS ON
BOV
SAPR4
SANEPAR PN
BOV
RPMG3
PET MANGUINH ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados